WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2016 meeting (3 year revision) are listed below.  See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2016.  

 

ATC codeATC level name (INN/generic name)DDDUnitAdm.route
A10BH06gemigliptin50mgO
A10BX09dapagliflozin10mgO
A11CC05colecalciferol20mcgO
G03XB02ulipristal5mgO
G04BD12mirabegron50mgO
H01AB01thyrotropin alfa0.9mgP
H01CB05pasireotide1.2mgP
J01DI02ceftaroline fosamil1.2gP
J04AK05bedaquiline86mgO
L04AA31teriflunomide14mgO
N03AX22perampanel8mgO
N07XX08tafamidis20mgO
R03BB05aclidinium bromide 1)0.644mgInhal powder
R03BB06glycopyrronium bromide 2)44mcgInhal powder
R05CB16mannitol0.8gInhal powder
R07AX02ivacaftor0.3gO
1) Refers to aclidinium, delivered dose
2) refers to glycopyrronium, delivered dose

Last updated: 2016-09-29